Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Plucked hair follicles can help diagnose scalp lupus.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Restoring hair follicle immune privilege may help treat alopecia areata.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

ILC1-like cells can independently cause alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.